ND

Nihit Duggal

Active Director Director DIN 06563271
DIN 06563271 First appointment May 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since May 2013
Shareholding value •••• Premium profile

About Nihit Duggal

Data last updated:

Nihit Duggal is a Director at La Renon Healthcare Private Limited (since 2023), Director at Stanford Laboratories Private Ltd (since 2015) and Director at Stanford Biosciences Private Limited (since 2013). The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹1,866 Cr; the largest is La Renon Healthcare Private Limited at ₹1,686 Cr (FY 2025). Earlier, Nihit Duggal was a Director at Stanford Lifecare Private Limited (from 2020).

DIN 06563271
Primary Designation Director
Industry Pharma
First Appointment 23 May 2013
Oldest Company Age 40 yrs
Largest company La Renon Healthcare Private Limited · ₹1,686 Cr (FY 2025)
Combined revenue ₹1,866 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
La Renon Healthcare Private Limited U24233GJ2007PTC051467
Director03 Jun 20232007₹1,686 Cr (FY 2025)Active
Stanford Laboratories Private Ltd U74899DL1985PTC022656
Director08 Jun 20151985₹178 Cr (FY 2025)Active
Stanford Biosciences Private Limited U74900DL2013PTC252562
Director23 May 20132013₹1.78 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Stanford Lifecare Private Limited U24304DL2020PTC363402
Director23 Apr 20202020₹1.5 Lakh (FY 2024)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Stanford Lifecare Private Limited
Stanford Laboratories Private Ltd
Stanford Biosciences Private Limited
La Renon Healthcare Private Limited
Premium access

Shareholding and investment profile for Nihit Duggal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nihit Duggal

Nihit Duggal currently holds 3 directorships: La Renon Healthcare Private Limited (Director, since 03 Jun 2023, revenue ₹1,686 Cr (FY 2025)); Stanford Laboratories Private Ltd (Director, since 08 Jun 2015, revenue ₹178 Cr (FY 2025)); Stanford Biosciences Private Limited (Director, since 23 May 2013, revenue ₹1.78 Cr (FY 2025)).

Nihit Duggal was first appointed on 23 May 2013 as Director at Stanford Biosciences Private Limited. The most recent appointment on record is 03 Jun 2023 at La Renon Healthcare Private Limited.

The 3 current companies of Nihit Duggal that report revenue have a combined latest revenue of ₹1,866 Cr: La Renon Healthcare Private Limited ₹1,686 Cr (FY 2025); Stanford Laboratories Private Ltd ₹178 Cr (FY 2025); Stanford Biosciences Private Limited ₹1.78 Cr (FY 2025).

Nihit Duggal held 1 earlier board appointment: Stanford Lifecare Private Limited (Director, from 23 Apr 2020).

The current boards of Nihit Duggal's companies include Anshul Agarwal (La Renon Healthcare Private Limited), Bharadwaj Thiruvenkata Venkatavaraghavan (La Renon Healthcare Private Limited), Bharat Singh (La Renon Healthcare Private Limited), Krunal Akshaykumar Shah (La Renon Healthcare Private Limited), Kshitij Pankaj Sheth (La Renon Healthcare Private Limited), Pankaj Kumar Singh (La Renon Healthcare Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available